Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perrigo
PRGO
|
+$672M |
| 2 |
Merck
MRK
|
+$608M |
| 3 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$384M |
| 4 |
Las Vegas Sands
LVS
|
+$378M |
| 5 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$303M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ralph Lauren
RL
|
+$518M |
| 2 |
eBay
EBAY
|
+$474M |
| 3 |
Estee Lauder
EL
|
+$435M |
| 4 |
Goldman Sachs
GS
|
+$323M |
| 5 |
TechnipFMC
FTI
|
+$304M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Consumer Discretionary | 13.85% |
| 3 | Communication Services | 11.23% |
| 4 | Technology | 10.46% |
| 5 | Energy | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Fortinet
FTNT
$112B
| $75.1M | 0.07% |
17,037,400
+3,099,375
| +22% | +$13.6M |
|
252
General Motors
GM
$80.9B
| $75M | 0.07% |
2,177,840
+242,194
| +13% | +$8.89M |
|
253
Acadia Pharmaceuticals
ACAD
$4.51B
| $74.2M | 0.07% |
3,049,417
+1,485,866
| +95% | +$37.6M |
|
254
Bank of America
BAC
$429B
| $74M | 0.07% |
4,300,038
+1,476,473
| +52% | +$24.8M |
|
255
Accenture
ACN
$106B
| $73.9M | 0.07% |
+926,655
| New | +$76.1M |
|
256
Urban Outfitters
URBN
$6.46B
| $73.6M | 0.07% |
2,018,394
-180,131
| -8% | -$6.56M |
|
257
AstraZeneca
AZN
$269B
| $73.5M | 0.07% |
+1,132,321
| New | +$73.1M |
|
258
Caterpillar
CAT
$361B
| $72.8M | 0.07% |
+732,647
| New | +$69.1M |
|
259
Alliant Energy
LNT
$18.6B
| $72.7M | 0.07% |
2,558,220
| – | – |
|
|
WBC
260
DELISTED
WABCO HOLDINGS INC.
WBC
| $72M | 0.07% |
681,787
+24,028
| +4% | +$2.32M |
|
|
RDC
261
DELISTED
Rowan Companies Plc
RDC
| $71.8M | 0.07% |
2,131,634
-73,144
| -3% | -$2.39M |
|
262
Ulta Beauty
ULTA
$21.8B
| $71.5M | 0.07% |
733,410
-234,967
| -24% | -$21.2M |
|
263
Curtiss-Wright
CW
$25.1B
| $71.3M | 0.07% |
1,122,871
+165,033
| +17% | +$10.4M |
|
264
Designer Brands
DBI
$315M
| $70.7M | 0.07% |
1,972,386
+66,097
| +3% | +$2.55M |
|
265
Alnylam Pharmaceuticals
ALNY
$38.3B
| $70.6M | 0.07% |
1,052,122
+33,966
| +3% | +$2.63M |
|
266
CMS Energy
CMS
$23B
| $70.6M | 0.07% |
2,409,556
-353,677
| -13% | -$9.8M |
|
267
Aptiv
APTV
$12.3B
| $70.5M | 0.07% |
+1,038,802
| New | +$66.3M |
|
|
DBD
268
DELISTED
Diebold Nixdorf Incorporated
DBD
| $70.3M | 0.07% |
1,761,414
+801,491
| +83% | +$28.9M |
|
269
GE Aerospace
GE
$364B
| $69.2M | 0.07% |
557,393
+43,994
| +9% | +$5.43M |
|
270
Cheesecake Factory
CAKE
$5.03B
| $69M | 0.07% |
1,449,571
-5,015
| -0.3% | -$234K |
|
271
Stratasys
SSYS
$666M
| $68.4M | 0.07% |
644,829
-39,280
| -6% | -$4.7M |
|
|
PNK
272
DELISTED
Pinnacle Entertainment Inc.
PNK
| $68.2M | 0.07% |
2,879,550
-264,843
| -8% | -$6.21M |
|
273
Ameren
AEE
$30.4B
| $68.1M | 0.07% |
1,652,908
+383,070
| +30% | +$14.8M |
|
274
Old Dominion Freight Line
ODFL
$46.3B
| $68.1M | 0.07% |
3,598,968
+718,044
| +25% | +$13M |
|
275
Heartland Express
HTLD
$1.01B
| $67.6M | 0.06% |
2,980,220
+319,903
| +12% | +$6.69M |
|
Similar funds
Jennison Associates's Q1 2014 Portfolio in Review
As of Q1 2014, Jennison Associates held 826 positions worth $105B, up 2.6% from $102B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Jennison Associates's Q1 2014 filing shows 122 new, 275 increased, 321 reduced and 94 closed positions. Its largest new stake was Perrigo: 4,257,843 shares worth $659M. The largest sale was Ralph Lauren, an estimated $518M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q1 2014 buy was Perrigo: 4,257,843 shares worth $659M.
- Jennison Associates added most to Merck in Q1 2014, an estimated $608M increase.
- Jennison Associates's biggest Q1 2014 reduction was Estee Lauder, cutting an estimated $435M.
- Jennison Associates fully exited Ralph Lauren in Q1 2014, selling an estimated $518M.
- Jennison Associates's ten largest holdings make up 18% of its $105B portfolio in Q1 2014.
- Jennison Associates opened 122 new positions and closed 94 in Q1 2014.
- Jennison Associates's portfolio value rose 2.6% quarter-over-quarter to $105B.
Based on Jennison Associates's 13F filing for Q1 2014, filed 7 May 2014.